Literature DB >> 21768354

Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids.

Varun Gauba1, Jan Grünewald, Vanessa Gorney, Lisa M Deaton, Mingchao Kang, Badry Bursulaya, Weijia Ou, Richard A Lerner, Christian Schmedt, Bernhard H Geierstanger, Peter G Schultz, Teresa Ramirez-Montagut.   

Abstract

The site-specific incorporation of the unnatural amino acid p-nitrophenylalanine (pNO(2)Phe) into autologous proteins overcomes self-tolerance and induces a long-lasting polyclonal IgG antibody response. To determine the molecular mechanism by which such simple modifications to amino acids are able to induce autoantibodies, we incorporated pNO(2)Phe, sulfotyrosine (SO(3)Tyr), and 3-nitrotyrosine (3NO(2)Tyr) at specific sites in murine TNF-α and EGF. A subset of TNF-α and EGF mutants with these nitrated or sulfated residues is highly immunogenic and induces antibodies against the unaltered native protein. Analysis of the immune response to the TNF-α mutants in different strains of mice that are congenic for the H-2 locus indicates that CD4 T-cell recognition is necessary for autoantibody production. IFN-γ ELISPOT analysis of CD4 T cells isolated from vaccinated mice demonstrates that peptides with mutated residues, but not the wild-type residues, are recognized. Immunization of these peptides revealed that a CD4 repertoire exists for the mutated peptides but is lacking for the wild-type peptides and that the mutated residues are processed, loaded, and presented on the I-A(b) molecule. Overall, our results illustrate that, although autoantibodies are generated against the endogenous protein, CD4 cells are activated through a neo-epitope recognition mechanism. Therefore, tolerance is maintained at a CD4 level but is broken at the level of antibody production. Finally, these results suggest that naturally occurring posttranslational modifications such as nitration may play a role in antibody-mediated autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768354      PMCID: PMC3150954          DOI: 10.1073/pnas.1110042108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  68 in total

1.  Goodpasture's disease--new secrets revealed.

Authors:  David J Salant
Journal:  N Engl J Med       Date:  2010-07-22       Impact factor: 91.245

2.  Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Authors:  Vadim Pedchenko; Olga Bondar; Agnes B Fogo; Roberto Vanacore; Paul Voziyan; A Richard Kitching; Jörgen Wieslander; Clifford Kashtan; Dorin-Bogdan Borza; Eric G Neilson; Curtis B Wilson; Billy G Hudson
Journal:  N Engl J Med       Date:  2010-07-22       Impact factor: 91.245

Review 3.  Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?

Authors:  Morten Asser Karsdal; Kim Henriksen; Diana Julie Leeming; Thasia Woodworth; Efstathios Vassiliadis; Anne-Christine Bay-Jensen
Journal:  Clin Biochem       Date:  2010-04-08       Impact factor: 3.281

4.  Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells.

Authors:  L Chazotte-Aubert; P Hainaut; H Ohshima
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

5.  Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system.

Authors:  Antonio Carrillo-Vico; Melanie D Leech; Stephen M Anderton
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

6.  Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.

Authors:  L B Pritzker; S Joshi; J J Gowan; G Harauz; M A Moscarello
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

7.  Nitrated and oxidized plasma proteins in smokers and lung cancer patients.

Authors:  B Pignatelli; C Q Li; P Boffetta; Q Chen; W Ahrens; F Nyberg; A Mukeria; I Bruske-Hohlfeld; C Fortes; V Constantinescu; H Ischiropoulos; H Ohshima
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

8.  Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.

Authors:  Yili Li; Florence R Depontieu; John Sidney; Theresa M Salay; Victor H Engelhard; Donald F Hunt; Alessandro Sette; Suzanne L Topalian; Roy A Mariuzza
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

9.  Efficient expression of tyrosine-sulfated proteins in E. coli using an expanded genetic code.

Authors:  Chang C Liu; Susan E Cellitti; Bernhard H Geierstanger; Peter G Schultz
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.

Authors:  A L Zarling; S B Ficarro; F M White; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  23 in total

1.  Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.

Authors:  Yingwen Liu; Yanghui Bi; Jia Lin; Lei Cao; Bing He; Zhi Zhang; Yongping Cui; Xuemei Zhang
Journal:  Tumour Biol       Date:  2014-11-15

Review 2.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

3.  Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.

Authors:  M Benjamin Hock; Karen E Thudium; Montserrat Carrasco-Triguero; Nikolai F Schwabe
Journal:  AAPS J       Date:  2014-11-08       Impact factor: 4.009

4.  Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.

Authors:  Vincent J Venditto; Douglas S Watson; Michael Motion; David Montefiori; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

Review 5.  Therapeutic applications of an expanded genetic code.

Authors:  Sophie B Sun; Peter G Schultz; Chan Hyuk Kim
Journal:  Chembiochem       Date:  2014-07-18       Impact factor: 3.164

Review 6.  Future prospects for noncanonical amino acids in biological therapeutics.

Authors:  Arlinda Rezhdo; Mariha Islam; Manjie Huang; James A Van Deventer
Journal:  Curr Opin Biotechnol       Date:  2019-04-08       Impact factor: 9.740

Review 7.  Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Authors:  Heather E Allen Reish; David G Standaert
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 8.  At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.

Authors:  Han Xiao; Peter G Schultz
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.

Authors:  Christoph Kessel; Kutty S Nandakumar; Francis B Peters; Varun Gauba; Peter G Schultz; Rikard Holmdahl
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

10.  Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.

Authors:  Maria Isaguliants; Olga Krotova; Stefan Petkov; Juris Jansons; Ekaterina Bayurova; Dzeina Mezale; Ilze Fridrihsone; Athina Kilpelainen; Philip Podschwadt; Yulia Agapkina; Olga Smirnova; Linda Kostic; Mina Saleem; Oleg Latyshev; Olesja Eliseeva; Anastasia Malkova; Tatiana Gorodnicheva; Britta Wahren; Ilya Gordeychuk; Elizaveta Starodubova; Anastasia Latanova
Journal:  Microorganisms       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.